Remasog, Johaina .

HRN: 29-08-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/11/2026
06/17/2026
IVT
2.25g
Q6H
Pleural Effusion, Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: